Compound ID | 276

PD-0162819

Class: Biotin carboxylase inhibitor

Spectrum of activity: Gram-positive
Details of activity: In static concentration time-kill and chemostat in vitro study, PD-0162819 was active against H. influenzae
Institute where first reported: Pfizer, USA
Year first mentioned: 2009
Highest developmental phase: Preclinical
Development status: Inactive

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.